Coagulation disorders during treatment with cefazolin and rifampicin: rare but dangerous

J Bone Jt Infect. 2021 Apr 1;6(5):131-134. doi: 10.5194/jbji-6-131-2021. eCollection 2021.

Abstract

We describe a 79-year-old man with spondylodiscitis and unknown pathogen, treated with cefazolin and rifampicin. He developed a massive digestive hemorrhage. Prothrombin time was prolonged with severe vitamin-K-dependent clotting-factor deficiency. Severe bleeding can occur during cefazolin and rifampicin use. This deficiency should be assessed before prescribing cefazolin-rifampicin and prothrombin time monitored.

Publication types

  • Case Reports